Untargeted metabolomics and infrared ion spectroscopy identify biomarkers for pyridoxine-dependent epilepsy. [PDF]
Engelke UF +30 more
europepmc +1 more source
Is impaired energy production a novel insight into the pathogenesis of pyridoxine-dependent epilepsy due to biallelic variants in ALDH7A1? [PDF]
Minenkova A +7 more
europepmc +1 more source
Early-onset pyridoxine-dependent epilepsy due to ALDH7A1 deficiency: the first genetically confirmed case from Palestine. [PDF]
Pujee BK +6 more
europepmc +1 more source
Pyridoxine-dependent epilepsy (PDE-ALDH7A1) in adulthood: A Dutch pilot study exploring clinical and patient-reported outcomes. [PDF]
Tseng LA +9 more
europepmc +1 more source
Classical and Emerging Biomarkers in Pyridoxine-Dependent Epilepsy (PDE-ALDH7A1): Implications for Early Diagnosis and Therapeutic Development. [PDF]
Abedrabbo M +3 more
europepmc +1 more source
Potential of AON therapy targeting AASS: A promising molecular therapy for pyridoxine-dependent epilepsy. [PDF]
Salih MA.
europepmc +1 more source
Vitamin K as an add-on therapy in pyridoxine-dependent epilepsy. [PDF]
Houten SM.
europepmc +1 more source
Chromothriptic Translocation t(1;18): A Paradigm of Genomic Complexity in a Child with Normal Intellectual Development and Pyridoxine-Dependent Epilepsy. [PDF]
Falsaperla R +13 more
europepmc +1 more source
Targeting Lysine α-Ketoglutarate Reductase to Treat Pyridoxine-Dependent Epilepsy. [PDF]
Liang Z +6 more
europepmc +1 more source
Analysis of clinical features and genetic variants in Chinese children with pyridoxine-dependent epilepsy: a case series study. [PDF]
Yu X +5 more
europepmc +1 more source

